New guidelines on migraine prevention reflect increasing options for patients
“There has been a wealth of new treatment available” for migraine prevention, said a co-author of new guidelines…
Read at source →Source
STAT News
Medicine, biotech, and health policy
Health · 688 articles · page 14 of 20 · fetched 38 minutes ago
STAT+: Trump strikes nine more deals with drugmakers to lower prices
President Trump on Monday announced the next round of pricing deals with drugmakers, with nine new companies making…
Read at source →
STAT+: Can buying a drug patent application be seen as a bid to prolong a monopoly?
A drug patent case involving Amgen is being closely watched given its potential implications for pharmaceutical patent…
Read at source →
AdSponsoredSiguimi
Pure chronological social — no algorithm
See who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
STAT+: GLP-1 drugs are almost single-handedly forcing employers to reconsider workers’ health care
Another hospital system sues CVS Health, how Medicaid cuts will change everything, and more
Read at source →
STAT+: We’re reading about drug pricing deals, a new cancer therapy approval, and more
In today's Pharmalittle newsletter, drug pricing deals, a new cancer therapy approval, and more of the latest pharma…
Read at source →
STAT+: Can a pregnancy hormone steer a cardiovascular treatment?
Caution and survival in radiopharmaceuticals, mRNA skepticism, and more biotech news from The Readout
Read at source →
A winner, a loser, and a mid-stage signal from a major cardiology research conference
The mental health system after Lindsay Clancy, pushing boundaries for new radiopharmaceuticals, and more health news…
Read at source →
Opinion: The most shocking thing about the latest statistics on CTE in football is that we find them so shocking
The latest study on CTE in football players “quantifies but does not reveal a problem,” writes Emily Harrison, a…
Read at source →
STAT+: After a rough stretch, mRNA gets a boost — at least for now
With clinical success on a personalized mRNA vaccine for melanoma, experts are hoping for a more stable future for the…
Read at source →
STAT+: Cadre of radiopharmaceuticals experts pushes the bounds in cancer therapy
Researchers believe radiopharmaceuticals have great promise as cancer treatments. But are they using them too timidly?
Read at source →
STAT+: FDA approves Protagonist and Takeda’s drug for rare blood cancer
Mimrylo, from Takeda and Protagonist, is a new kind of treatment for the blood cancer polycythemia vera.
Read at source →
STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua
An AstraZeneca heart disease trial failure has put Alnylam under pressure. It's mounting a defense of its medicines.
Read at source →
STAT+: A Novartis drug cut inflammation. Can it improve heart outcomes?
A newly acquired Novartis drug cut signs of inflammation. The test will be whether that can improve people's heart…
Read at source →
Juul gets OK to sell updated vaping device with age-gating technology
Juul has received FDA clearance to sell an updated version of its e-cigarette, which includes an optional…
Read at source →
Opinion: The unintended consequences of the Lindsay Clancy case
“We are concerned the [Lindsay] Clancy case could make psychiatrists more reluctant to treat mothers with mental…
Read at source →
STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching
Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news
Read at source →
At a federal autism advisory committee meeting, members double down on long-debunked theories
RFK Jr.'s vaccine questions in Samoa, former Stanford president rebuts fraud allegations, and more health news from…
Read at source →STAT+: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and more
Pharma news from the Pharmalot campus, brought to you by the Pharmalittle newsletter
Read at source →
STAT+: Cytokinetics details trial win for what could be its next approval
It took Cytokinetics 27 years to win its first drug approval. With the results of a new trial, its second could come…
Read at source →
STAT+: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs
AstraZeneca detailed the surprise failure of a closely watched heart disease trial, a study with ripple effects for a…
Read at source →
Vaccines take center stage at federal autism advisory committee
Comments about vaccines overshadowed an advisory committee meeting to discuss a plan for boosting federal funding for…
Read at source →
Opinion: A billing code was supposed to incentivize relationship-based primary care for Medicare patients. It may not be working as hoped
Primary care is much more than what happens during an office visit, writes physician Ishani Ganguli.
Read at source →
Opinion: We quit the CDC last year. The problems we protested remain
How disease spreads and the risks and benefits of interventions are questions for science, not for ideology.
Read at source →
STAT+: FDA approves Roivant therapy for rare autoimmune disease
The FDA approved a new medicine from Roivant and its subsidiary Priovant for the treatment of dermatomyositis, a rare…
Read at source →
STAT+: Former Stanford president releases emails to rebut fraud and cover-up allegations in new book
Marc Tessier-Lavigne released new details from his research and travel in an attempt to refute allegations in a new…
Read at source →
STAT+: CMS plans launch event for ACCESS, the Medicare chronic care pilot
In this edition of STAT Health Tech: CMS plans a launch event for Medicare chronic care pilot, and what the Meta…
Read at source →
STAT+: Hospitals plot their response to funding cuts
Hospital prep a lobbying push, RFK Jr. faces more bad news on measles, and the cancer drug that helped Ben Sasse gets…
Read at source →
What’s in Merck and Moderna’s cancer vaccine algorithm?
A heart drug failure, RevMed's pancreatic cancer drug approved, and more biotech news from The Readout
Read at source →STAT+: Pharmalittle: We’re reading about a pancreatic cancer drug approval, a Trump deal with biotechs, and more
The FDA approved a life-extending treatment for advanced pancreatic cancer from Revolution Medicines that is the first…
Read at source →
RFK Jr. said a Samoa trip had nothing to do with vaccines. New documents refute that
Health secretary Robert F. Kennedy Jr. said a Samoa trip had nothing to do with vaccines. New documents obtained by The…
Read at source →
Decoding DEA action on kratom-related substances
RFK Jr. downplays measles threat, FDA approves pancreatic drug, and more health news from Morning Rounds
Read at source →
STAT+: Cassidy criticizes FDA oversight of abortion pill manufacturers in new report
The report raises a high-profile issue for Heidi Overton as she faces confirmation as FDA commissioner.
Read at source →
STAT+: Alnylam’s heart drug troubles take center stage at a cardiology conference
The European Society of Cardiology Congress that kicks off Friday in Munich will be a consequential meeting for Alnylam…
Read at source →
STAT+: The mystery of Moderna’s magic algorithm
A personalized cancer vaccine developed by Moderna and Merck may be a triumph of immunology and cancer biology. It…
Read at source →
A state gave sheriffs 20% of its opioid settlement cash. We followed the money
KFF Health News examines how sheriffs are spending opioid settlement money, finds they're spending millions on police…
Read at source →
Hospitals are plotting a long-shot push to roll back $1 trillion in Medicaid cuts
Inside health systems' efforts to mitigate massive funding cuts.
Read at source →